Provider
Upcoming-policies-effective-December-6-2021.pdf
Search Results
Displaying 2171 - 2180 of 3661 results
Provider
Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) Inhibitors - Medicaid - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Program effective Date: Feb 01, 2025
Provider
Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) Inhibitors - Commercial - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Program effective Date: Feb 01, 2025
Provider
Oral Anticoagulant - Bevyxxa® (betrixaban), Eliquis® (apixaban), Pradaxa® (dabigatran), Savaysa™ (edoxaban), Xarelto® (rivaroxaban) - Medicaid
Quantity Limit
Program effective Date: Sep 01, 2024
Provider
2021 October Bulletins
Program effective Date: Oct 01, 2021
Provider
P58-21 2022 Renewal Changes Summary for Institutional Providers
Program effective Date: Oct 01, 2021
Provider
P54-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: Oct 01, 2021
Provider
P56-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective December 6, 2021
Program effective Date: Oct 01, 2021
Provider
Lupus - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Commercial - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2025